To test these findings in other tumor cell types, we expanded our analysis to a panel of breast cancer cell lines where we detected a range of p62/SQSTM1 protein expression (Figure 5C, middle) and drug sensitivity to MK2206 (Figure 5C, bottom). This evidence concerns the gene SQSTM1 and breast carcinoma.